当前位置: 首页 > 医学版 > 期刊论文 > 内科学 > 糖尿病学杂志 > 2005年 > 第1期 > 正文
编号:11256201
Impairment of Host Resistance to Listeria monocytogenes Infection in Liver of db/db and ob/ob Mice
     1 Third Department of Medicine, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan

    2 Department of Bacteriology, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan

    3 Department of Molecular Biology, Institute of Brain Science, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan

    4 Department of Medical Technology, Hirosaki University School of Health Sciences, Hirosaki University, Hirosaki, Aomori, Japan

    5 Department of Radiology, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan

    ABSTRACT

    Leptin is an adipocyte-derived hormone that regulates a number of physiological functions, including energy homeostasis and immune function. In immune responses, leptin plays a role in the induction of inflammation. We investigated a role of leptin in Listeria monocytogenes infection using leptin receptoreCdeficient db/db mice and leptin-deficient ob/ob mice. These mutant mice were highly susceptible to L. monocytogenes, and the elimination of bacteria from the liver was inhibited. After infection, the induction of monocyte chemoattractant protein-1 (MCP-1) and KC mRNA in the liver of db/db mice and the MCP-1 mRNA expression in the liver of ob/ob mice was decreased compared with their heterozygote littermates. Leptin replacement in ob/ob mice resulted in improvement of anti-listerial resistance and the MCP-1 mRNA expression. The elimination of L. monocytogenes was significantly enhanced, and the expression of MCP-1 and KC mRNA was completely reversed in db/db mice by insulin treatment. These results suggest that leptin is required for host resistance to L. monocytogenes infection and that hyperglycemia caused by leptin deficiency is involved in the inefficient elimination of bacteria from the liver. Moreover, defect of MCP-1 expression in the liver may be involved in the attenuated host resistance in these mutant mice.

    Leptin is a small peptide hormone secreted primarily by the adipocyte. Leptin-deficient ob/ob mice (1,2) and receptor-deficient db/db mice (3) were characterized initially as diabetes-obesity syndromes (4). Moreover, these animals exhibit a severe dysregulation of reproductive and hormonal traits (5) as well as a disturbance of hematopoietic and immune functions (6).

    Lord et al. (7) first reported that leptin increases T-helper (Th)1 cytokine production and suppresses Th2 cytokine production. Implication of leptin in inflammatory responses, including experimental autoimmune encephalomyelitis (8) and experimental arthritis (9), was demonstrated. On the other hand, a recent study showed that neutrophils express leptin receptors and that leptin enhances oxidative species production by neutrophils (10). Moreover, ob/ob mice exhibit impaired host resistance to intratracheal gram-negative Klebsiella pneumoiae infection due to impaired alveolar macrophage phagocytosis and neutrophil complement-mediated phagocytosis (11,12).

    Diabetes is often identified as an independent risk factor for infections (13,14). We were interested in investigating the role of leptin and its correlation to host resistance to Listeria monocytogenes infection. L. monocytogenes is an intracellular-growing bacterium that is ordinarily nonpathogenic to healthy people; however, it is important as an opportunistic pathogen. The individuals at highest risk are pregnant women and their fetuses, new born infants, debilitated elderly people, and immunocompromized hosts including patients with diabetes (15). Host resistance to L. monocytogenes is controlled by cell-mediated immunity and regulated endogenous cytokines. This pathogen promotes the induction of the Th1 response, and interferon (IFN)- plays a critical role in anti-listerial resistance (16eC18). Activated macrophages are the major effector cells in anti-listerial resistance (19), while neutrophils play a critical role in the resistance, especially early in infection (20). Chemokines are essential for accumulation of neutrophils and macrophages at the infectious foci (21). It was reported that mice lacking CCR2, a receptor for monocyte chemoattractant protein-1 (MCP-1) (CCL2), are highly susceptible to L. monocytogenes infection (22). Similarly, anti-listerial resistance is reportedly decreased in mice lacking CXCR3, a receptor for macrophage inflammatory protein-2 (MIP-2) (CXCL8) and KC (23). MCP-1 is a potent monocyte activator that has been associated with monocytic infiltration in several inflammatory diseases, and MIP-2 and KC are powerful chemoattractants for neutrophils (24).

    In the present study, we investigated host resistance to L. monocytogenes infection in db/db and ob/ob mice. We showed that these mutant mice were highly susceptible to this pathogen, and the elimination of bacteria from liver from these mice was inhibited. We demonstrate that leptin is required for host resistance to L. monocytogenes infection and that hyperglycemia caused by leptin deficiency is involved in the inefficient elimination of bacteria from the liver. Moreover, a defect of MCP-1 expression in liver may be involved in the attenuated host resistance in these mutant mice.

    RESEARCH DESIGN AND METHODS

    Female C57BL/KsJ-db/db mice and their lean heterozygote littermates (db/m) were purchased from Clea Japan (Tokyo, Japan). Female C57BL/6j-ob/ob mice and their lean heterozygote littermates (ob/) were obtained from The Jackson Laboratories (Bar Harbor, ME). Mice were maintained under specific pathogen-free condition at the Institute for Animal Experiment, Hirosaki University School of Medicine. All mice were allowed free access to water and food and were studied at 13eC15 weeks of age. This study was carried out in accordance with the Guidelines for Animal Experimentation of Hirosaki University.

    Bacterial infection.

    L. monocytogenes 1b 1684 was prepared as previously described (25). The concentration of washed cells was adjusted spectrophotometrically at 550 nm, and cells were stored at eC80°C until use. Mice were infected intravenously with 0.2 ml of a solution containing 5 x 104 or 5 x 105 colony-forming units (CFU) of viable L. monocytogenes cells in 0.01 mol/l PBS (pH 7.4). The numbers of viable L. monocytogenes in the liver and spleen of infected animals were established by plating serial 10-fold dilutions of organ homogenates in RPMI-1640 medium (Nissui, Tokyo, Japan) containing 1% CHAPS (3-[(3-cholamidopropyl)-dimethylammonio]-1-propansulfonate) (Wako, Osaka, Japan) on tryptic soy agar (BD Biosciences, Sparks, MD). Colonies were routinely counted 18eC24 h later.

    Histology and immunohistochemistry.

    The liver tissues from db/db, db/m, ob/ob, and ob/ mice were fixed with 10% phosphate-buffered formalin and embedded in paraffin. Four-micrometer-thick sections were prepared, deparaffinized, and stained with hematoxylin and eosin for routine histopathological examination. For immunohistochemistry, deparaffinized sections were immunostained using the avidin-biotin-peroxidase complex (ABC) method with a Vectastain ABC kit (Vector, Burlingame, CA). They were then incubated with rat anti-mouse neutrophil antibody (diluted 1:100; Serotec Product, Oxford, U.K.), rabbit anti-human T-cell antibody CD3 (diluted 1:10; DakoCytomation, Carpinteria, CA), or rat anti-mouse macrophage antibody F4/80 (diluted 1:100; Serotec Product) overnight at 4°C. Diaminobenzidine was used as the chromogen. The immunolabeled sections were counterstained with hematoxylin. For immunostaining with CD3, the sections were pretreated for 30 min at 37°C with proteinase K (Gibco, Gaithersburg, MD) at a concentration of 10 e/ml. For immunostaining with anti-neutrophil antibody, the sections were heated in 0.01 mol/l sodium citrate buffer (pH 6.0) by microwave for 15 min.

    Quantitative analysis of inflammatory cell density was performed by counting the number of neutrophils, T-cells, and macrophages using the specific antibodies described above. A blinded observer counted the inflammatory cells in the liver in 10 random high-power (x200) fields of each immunohistochemically stained section.

    Real-time quantitative RT-PCR.

    Total RNA was isolated from pieces of spleen and liver (0.05 g each) using a guanidium thiocyanate-phenol-chloroform single-step method (26). First-strand cDNAs were synthesized by reverse transcription of 1 e total RNA using random primers (Takara, Shiga, Japan) and reverse transcriptase Moloney murine leukemia virus (Invitrogen, CA). The following primers were used for MCP-1, forward 5'-ACTGAAGCCAGCTCTCTCTTCCTC-3' and reverse 5'-TTCCTTCTTGGGGTCAGCACAGAC-3'; for KC, forward 5'-GGATTCACCTCAAGAACATCCAGAG-3' and reverse 5'-CACCCTTCTACTAGCA CAGTGGTTG-3'; for MIP-2, forward 5'-GAACAAAGGCAAGGCTAACTGA-3' and reverse 5'-AACATAACAACATCTGGGCAAT-3'; and for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forward 5'-TGAAGGTCGG TGTGAACGGATTTGG-3' and reverse 5'-ACGACATACTCAGCACCAGCATCAC-3' (27). The predicted sizes of amplified products for MCP-1, KC, MIP-2, and GAPDH were 274, 454, 204, and 277 bp, respectively. SYBER Green Supermix (Bio-Rad) was used as a PCR solution. PCR was run following protocol: initial activation of TaqDNA polymerase for 5 min at 94°C, 1 min at 94°C for denaturing, 2 min at 60°C for annealing, and 3 min at 72°C for elongation, and 40 PCR cycles were performed. All experiments were run in duplicate and nontemplate controls, and dissociation curves were used to detect primer-dimer conformation and nonspecific amplication. The threshold cycle (CT) of each target product was determined and set in relation to the amplification plot of GAPDH. The detection threshold is set to the log linear range of the amplification curve and kept constant (0.05) for all data analysis. Difference in CT · values (CT) of two genes was used to calculate the fold difference [fold difference = 2eC(CT of chemokine eC CT of GAPDH) = 2eCCT].

    Treatment with insulin or leptin.

    ob/ob mice were divided into a leptin-treated group and a nontreated group. One microgram per gram of body weight of recombinant murine leptin (Calbiochem, San Diego, CA) in 0.2 ml PBS or PBS only as a control was administered subcutaneously at 9:00 A.M. and 9:00 P.M. for 10 days (12). PBS only was administered as a control. db/db mice were divided into an insulin-treated group and a nontreated group. Blood glucose concentrations were measured at 10:00 A.M. with whole blood obtained from tail veins using a portable blood glucose analyzer (Abbott Japan, Tokyo, Japan). Insulin suspension containing 50 units human isophane insulin (Novo Nordisk Pharma, Tokyo, Japan) or 0.5 ml PBS as a control was administered subcutaneously at 6:00 P.M. for 14 days.

    Statistical evaluation of the data.

    Data were expressed as the mean ± SD, and the Student’s t test was used to determine the significance of the differences of inflammatory cell counts, bacterial counts, and cytokine titers in the specimens between the control and experimental groups. The generalized Wilcoxon test was used to determine the significance of differences in the survival rates.

    RESULTS

    Resistance to L. monocytogenes infection was decreased in db/db and ob/ob mice.

    Mice were infected intravenously with 5 x 105 CFU of viable L. monocytogenes, and survival was observed until day 10 of infection. All of the db/db mice died within 4 days, while most of their littermates, db/m mice, survived for 10 days (Fig. 1A) (P < 0.05). ob/ob mice also showed higher mortality compared with their heterozygote littermates, ob/ mice (Fig. 1B) (P < 0.05). Next, we investigated the kinetics of bacterial growth in the spleen and liver of db/db and db/m mice. To observe the bacterial growth comparatively, mice were infected with a nonlethal dose of L. monocytogenes. db/db and db/m mice were infected with 5 x 104 CFU of L. monocytogenes, and the bacterial numbers in the organs of mice were determined at various time points (Fig. 1C and D). In the spleen, no significant difference of the bacterial growth was observed between these two groups except 2 h after infection (Fig. 1C). In contrast, although the bacterial numbers were comparable in the liver of both mice until 8 h, the numbers in the liver of db/db mice were significantly higher than those of db/m mice after 12 h (P < 0.05) (Fig. 1D). Moreover, we assessed the growth of L. monocytogenes in the spleen and liver of ob/ob mice and their heterozygote littermates 48 h after infection. The bacterial number of liver of ob/ob mice was significantly higher than that of ob/ mice, but bacterial growth was similar in the spleen (Fig. 1E). These results suggest that db/db mice as well as ob/ob mice show a high susceptibility to L. monocytogenes infection compared with their heterozygote littermates.

    Histological comparison of the liver of db/db and ob/ob mice during L. monocytogenes infection.

    We assessed liver histology of db/db and ob/ob mice and their heterozygote littermates 6, 24, and 48 h after infection with 5 x 104 CFU of L. monocytogenes. Hydropic degeneration of hepatocytes and swelling of Kupffer cells were observed 6 h after inoculation with L. monocytogenes. Hydropic degeneration was much more severe in the db/db than in the db/m mice (Fig. 2A and B). Abscess formation occurred in the db/db mice, but not in the db/m mice, at and after 24 h. On the other hand, mononuclear cell infiltration was more prominent in the db/m mice than in the db/db mice at 48 h (Fig. 2A and B). Quantitative analysis revealed that the numbers of neutrophils, T-cells, and macrophages were significantly higher in the db/m than in the db/db mice (Fig. 3A). Consistent with previous studies (28), severe fatty degeneration was observed in the ob/ob mice but not in the ob/ mice (Fig. 2C and D). Mild hydropic degeneration of hepatocytes, swelling of Kupffer cells, and formation of abscesses were observed in both the ob/ob and the ob/ mice 48 h after infection. Hydropic degeneration and abscess formation were more severe in the ob/ob than in the ob/ mice. On the other hand, mononuclear cell infiltration was much more prominent in the ob/ than in the ob/ob mice (Fig. 2C and D). Quantitative analysis revealed that the majority of inflammatory cells in the ob/ mice were T-cells and that the numbers of T-cells and macrophages were significantly higher in the ob/ than in the ob/ob mice (Fig. 3B).

    Expression of chemokine mRNA is reduced in the liver of db/db and ob/ob mice.

    Chemokines including MCP-1, KC, and MIP-2 play an important role in the recruitment of phagocytes (22,23). We examined whether the impaired bacterial clearance exhibited by db/db and ob/ob mice is associated with the ability of chemokine expression. db/db and db/m mice were infected with 5 x 104 CFU of L. monocytogenes, and the expression of MCP-1, KC, and MIP-2 mRNA in the liver at various time points was determined by real-time quantitative PCR. The MCP-1 mRNA expression in the liver of db/m mice was significantly upregulated 42 h after infection compared with that in the db/db mice (Fig. 4A) (P < 0.05). Similarly, the KC mRNA expression in the liver of db/m mice was significantly higher than that in the db/db mice 24 h and 42 h after infection (Fig. 4B) (P < 0.05). However, the levels of MIP-2 mRNA in the liver of db/m mice were comparable with those in db/db mice during L. monocytogenes infection (Fig. 4C). In contrast, the expression of MCP-1, KC, and MIP-2 mRNA was equally increased in the spleen of db/db and db/m mice by L. monocytogenes infection (data not shown). We also assessed the chemokine mRNA expression in the liver of ob/ob and ob/ mice 42 h and 48 h after infection. At 48 h, the MCP-1 mRNA expression in the liver of ob/ mice was significantly upregulated compared with that in the ob/ob mice (Fig. 5B) (P < 0.05), while the levels of KC and MIP-2 mRNA in the liver of ob/ mice were comparable with those in ob/ob mice (Fig. 5C and D). Similar results were also obtained 42 h after infection (data not shown).

    Host resistance to L. monocytogenes infection and chemokine mRNA expression is improved by leptin replacement in ob/ob mice.

    We examined whether the impaired bacterial clearance and the expression of chemokine mRNA exhibited might be improved by injections of leptin. When ob/ob mice were injected with recombinant murine leptin at 12-h intervals for 10 days, the blood glucose level, body weight, and liver weight were reduced to the approximate values of ob/ mice (Table 1). The ob/ob mice were infected with 5 x 104 CFU of L. monocytogenes on the following day after the last injection of leptin or PBS, and the bacterial numbers in the liver were determined 48 h later (Fig. 5A). The growth of bacterial cells in the liver of leptin-treated ob/ob mice was significantly inhibited compared with that of the PBS-treated ob/ob mice. We next assessed histology of the liver of leptin-treated mice 48 h after infection. Fatty and hydropic degeneration of hepatocytes were much milder in the leptin-treated ob/ob mice than in the PBS-treated ob/ob mice. The number of abscesses was smaller in the leptin-treated ob/ob mice than in the PBS-treated ob/ob mice (Fig. 6A and B). We also determined the expression of MCP-1, KC, and MIP-2 mRNA in the liver by real-time quantitative PCR 48 h after infection. The MCP-1 mRNA expression in the leptin-treated ob/ob mice was improved to the level of ob/ mice (Fig. 5B). In contrast, the levels of KC and MIP-2 mRNA were not affected by the leptin treatment in the ob/ob mice (Fig. 5C and D). These results suggest that the absence of leptin contributes to decreases in anti-listerial resistance and MCP-1 mRNA expression in ob/ob mice.

    Host resistance to L. monocytogenes infection and chemokine mRNA expression are improved in db/db mice by insulin treatment.

    We next examined whether the impaired bacterial clearance exhibited might be associated with hyperglycemia. When db/db mice were injected with insulin for 14 days, the blood glucose levels were reduced to the approximate values of db/m mice (Table 1). Moreover, their body and liver weight were slightly decreased by insulin treatment. The db/db mice were infected with 5 x 104 CFU of L. monocytogenes on the following day after the last injection of insulin, and the bacterial numbers in the liver were determined 48 h later (Fig. 7A). The growth of bacterial cells in the liver of insulin-treated db/db mice was significantly decreased compared with that of the PBS-treated db/db mice (P < 0.05). We next assessed histology of the liver of insulin-treated mice 48 h after infection. Hydropic degeneration and abscess formation were milder in the insulin-treated db/db mice than in the PBS-treated db/db mice (Fig. 6C and D). We also determined the expression of MCP-1, KC, and MIP-2 mRNA in the liver by real-time quantitative PCR 48 h after infection. The expression of both MCP-1 and KC mRNA in the insulin-treated db/db mice was improved to the levels of db/m mice (Fig. 7B and C). In contrast, the level of MIP-2 mRNA expression was not improved by insulin treatment in the db/db mice (Fig. 7D). These results suggest that hyperglycemia is involved in the decrease of anti-listerial resistance and the expression of MCP-1 and KC in db/db mice.

    DISCUSSION

    Our study showed that leptin is a critical factor in host resistance to infection with an intracellular-growing bacterium, L. monocytogenes, as well as an extracellular-growing bacterium, K. pneumoniae (11,12). In this study, db/db and ob/ob mice were succumbed by sublethal L. monocytogenes infection (Fig. 1A and B). Death from listeriosis is caused by multiple organ failure, including liver damage (29). Indeed, the bacterial growth in the liver of db/db and ob/ob mice was significantly enhanced compared with that in their heterozygote littermates (Fig. 1D and E). These results suggested that leptin deficiency attenuates the defense against L. monocytogenes infection in liver.

    In this study, bacterial growth was quite different between the spleen and the liver of db/db and ob/ob mice (Fig. 1CeCE). Activated macrophages are the major effector cells in host resistance to L. monocytogenes infection (19), while neutrophils are also critical in the defense (20). Previous studies suggested that defense mechanisms to L. monocytogenes infection are different between spleen and liver (19,20,30); >60% of L. monocytogenes cells injected intravenously are recovered in the liver and multiply in hepatocytes. Massive infiltration of neutrophils occurs in the liver soon after. Explosive bacterial growth is revealed in the liver but not in the spleen of neutrophil-depleted mice early in infection. However, there have been little precise studies on the difference of defense mechanisms against L. monocytogenes infection between liver and spleen. In our histological observations, abscess formation occurred in the liver of db/db mice but not in the liver of db/m mice (Fig. 2A and B). Moreover, inflammatory cell infiltration including macrophages and neutrophils was more prominent in the db/m than in the db/db mice (Fig. 3A). Similarly, hydropic degeneration and abscess formation were more severe in the ob/ob than in the ob/ mice, and infiltration of inflammatory cells including macrophages and neutrophils was much more prominent in the ob/ than in the ob/ob mice (Fig. 2C and D). From these results, it is possible that dysregulation of bacterial clearance in the liver of db/db and ob/ob mice is caused by reducing infiltration of inflammatory cells.

    Chemokines are essential for accumulation of neutrophils and macrophages at the infectious foci (21). MCP-1 attracts and activates monocytes, and MIP-2 and KC are powerful chemoattractant for neutrophils (24). Mice lacking CCR2, a receptor for MCP-1, are highly susceptible to L. monocytogenes infection (22), although excessively produced MCP-1 results in higher sensitivity to the infection (31). Similarly, anti-listerial resistance is reportedly decreased in mice lacking CXCR3, a receptor for MIP-2 and KC (23). Implication of these chemokines in host resistance has also been reported in other bacterial infections such as Mycobacterium tuberculosis (32), Staphylococcus aureus (33), and Klebsiella pneumoniae (34). In this study, the induction of MCP-1 and KC mRNA expression, but not MIP-2 mRNA expression, by L. monocytogenes infection was suppressed in the liver of db/db mice (Fig. 4). In contrast, only MCP-1 mRNA expression was attenuated in ob/ob mice (Fig. 5). These results suggest that the decrease of MCP-1 might be involved in the attenuated anti-listerial resistance in the liver of db/db and ob/ob mice.

    In this study, the weight loss and the decrease of the blood glucose levels in ob/ob mice were observed when leptin was administrated in the same scheduled doses as that reported previously (12) (Table 1). The elimination of bacteria from the liver was significantly enhanced by leptin replacement (Fig. 4A). The degree of fatty and hydropic degeneration of hepatocytes and the number of abscesses were reduced by leptin replacement (Fig. 6A and B). Moreover, the MCP-1 mRNA expression in leptin-treated ob/ob mice was improved to the level of ob/ mice (Fig. 5B). These results suggest that leptin is able to restore anti-listerial resistance and MCP-1 production in leptin-deficient mice. Herein, the essential role of leptin in host resistance to L. monocytogenes infection was demonstrated by leptin-deficient mice and leptin replacement.

    Patients suffering from diabetes are recognized as a risk group for opportunistic infections including L. monocytogenes (13eC15). The available literature suggests two patterns of susceptibility to infections in the diabetic host. First, certain types of pulmonary infections may occur with an increased frequency in diabetic patients (35). Second, although certain pulmonary infections do not occur with increased frequency, they may be associated with increased morbidity and mortality in diabetic patients (36). In this study, hyperglycemia was improved by insulin treatment in db/db mice (Table 1). In parallel, the induction of MCP-1 and KC mRNA expression in the liver of insulin-treated db/db mice reversed to the levels of db/m mice (Fig. 7). These results suggested that hyperglycemia suppressed the expression of MCP-1 and KC mRNA in the liver of L. monocytogeneseCinfected db/db mice. On the other hand, the elimination of L. monocytogenes cells from the liver was recovered in insulin-treated db/db mice, but the improvement of resistance did not reach the levels of db/m mice (Fig. 7A). These results suggest that hyperglycemia is an important factor for the high susceptibility to L. monocytogenes infection. However, it is possible that other mechanisms mediated by leptin may be involved in the resistance of db/db mice.

    In conclusion, db/db and ob/ob mice were highly susceptible to L. monocytogenes, and suppressed clearance of bacteria was especially revealed in the liver. It is possible that the decreased expression of MCP-1 is involved in attenuated anti-listerial resistance. Leptin is required for host resistance to L. monocytogenes infection, and hyperglycemia is included in leptin-mediated host defense. The present findings may provide a novel approach to elucidate a mechanism of high susceptibility to infections in diabetes.

    GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IFN, interferon; MCP-1, monocyte chemoattractant protein-1; MIP-2, macrophage inflammatory protein-2; Th, T-helper

    REFERENCES

    Zhang Y, Proenca R, Maffel M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature372 :425 eC432,1994

    Halaas JL, Gajiwals KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science269 :543 eC546,1995

    Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstem JP: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell84 :491 eC495,1996

    Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia14 :141 eC148,1978

    Ahima RS, Saper CB, Flier JS, Elmquist JK: Leptin regulation of neuroendocrine systems. Front Neuroendocrinol21 :263 eC307,2000

    Fantussi G, Faggioni R: Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol68 :437 eC446,2000

    Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature394 :897 eC901,1998

    Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S: Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol166 :5909 eC5916,2001

    Busso N, So A, Chobaz-Peclat V, Morard C, martinez-Soria E, Talabot-Ayer, Gabay C: Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol168 :875 eC882,2002

    Caldefie-Chezet F, Poulin A, Tridon A, Sion B, Vasson M-P: Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action J Leukoc Biol69 :414 eC418,2001

    Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB: Leptin-decifient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol168 :4018 eC4024,2002

    Moore SI, Huffnagel GB, Chen G-H, White ES, Mancuso P: Leptin modulates neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun71 :4182 eC4185,2003

    Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H: Infection and diabetes: the case for glucose control. Am J Med72 :439 eC450,1982

    Joshi N, Caputo GM, Weitekamp MR, Karchmer AW: Infections in patients with diabetes mellitus. N Engl J Med341 :1906 eC1912,1999

    Skogberg K, Syrjanen J, Jahkola M, Renkonen OV, Paavonen J, Ahonen J, Kontiainen S, Ruutu P, Valtonen V: Clinical presentation and outcome of listeriosis in patients with and without immnosuppressive therapy. Clin Infect Dis14 :815 eC821,1992

    Hsieh C-S, Macatonis SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM: Development of Th1 CD4+ T-cells through IL-12 produced by Listeria-induced macrophages. Science260 :547 eC549,1993

    Buchmeier NA, Schreiber RD: Requirement of endogenous interferon- for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci U S A82 :7404 eC7408,1985

    Huang S, Hendriks W, Althage A, Hemmi S, Bluthmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the intereferon- receptor. Science259 :1742 eC1745,1993

    Mackaness GB: Cellular resistance to infection. J Exp Med116 :381 eC402,1962

    Conlan JW, North RJ: Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med179 :259 eC268,1994

    Luster AD: Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med338 :436 eC445,1998

    Kurihara T, Warr G, Loy J, Bravo R: Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med186 :1757 eC1762,1997

    Czuprynski CJ, Brown JF, Steinberg H, Carroll D: Mice lacking the murine interleukin-8 receptor homologue demonstrate paradoxical responses to acute and chronic experimental infection with Listeria monocytogenes. Microb Pathog24 :17 eC23,1998

    Chensue SW: Molecular machinations: chemokine signals in host-pathogen interactions. Clin Microbiol Rev14 :821 eC835,2001

    Nakane A, Minagawa T, Kohanawa M, Chen Y, Sato H, Moriyama M, Tsuruoka N: Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun57 :3331 eC3337,1989

    Chomczynski P, Sacci N: Single step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem162 :156 eC159,1987

    Ishida Y, Konda T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N: A pivotal involvement of IFN- in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J16 :1227 eC1236,2002

    Yang S, Lin H, Diehl AM: Fatty liver vulnerability to endotoxin-induced damage despite NF-B induction and inhibited caspase 3 activity. Am J Physiol Gastrointest Liver Physiol281 :G382 eCG392,2001

    Sasaki T, Mieno M, Udono H, Yamaguchi K, Usui T, Hara K, Shiku H, Nakayama E: Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine interferon in listerial infection. J Exp Med171 :1141 eC1154,1990

    Gregory SH, Sagnimeni AJ, Wing EJ: Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol157 :2514 eC2520,1996

    Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Crless CL, Rollins BJ: High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol155 :4838 eC4843,1995

    Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD: Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A98 :7958 eC7963,2001

    Kielian T, Barry B, Hickey WF: CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol166 :4634 eC4643,2001

    Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, Standiford TJ: Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis173 :159 eC165,1996

    Tauzon CU, Perez A, Kishiba T, Sheegren JN: Staphylococcus aureus among insulin-injecting diabetic patients. JAMA231 :1272 ,1975

    Robbins SL, Tucker AW Jr: The cause of death in diabetes: a report of 307 autopsied cases. N Engl J Med231 :865 ,1944(Shin Ikejima,, Sanae Sasa)